Why the Sigma Healthcare Ltd share price plunged 8% today

The Sigma Healthcare Ltd (ASX:SIG) share price has sunk 8% lower after the release of another trading update. Here's what you need to know…

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Unfortunately for its shareholders the Sigma Healthcare Ltd (ASX: SIG) share price is once again sinking significantly lower.

At the time of writing the pharmacy chain operator and distributor's shares are down almost 8% to 85.7 cents.

This means its shares are down close to 34% since the start of the year.

What happened?

This morning Sigma provided the market with yet another trading update and as you might have guessed, it wasn't a positive one.

According to today's release, Sigma has downgraded its full-year underlying earnings before interest and tax (EBIT) guidance from $95 million to around $90 million.

This downgrade is the result of management responding to tough trading conditions by taking steps to enhance its sales performance and market share growth.

Whilst it hasn't explained the steps it has taken, it seems apparent that Sigma is cutting prices in order to compete.

Should you buy the dip?

Things really don't look good for Sigma at the moment.

As well as potentially embarking on a price war with rivals Australian Pharmaceutical Industries Ltd (ASX: API) and the local pharmacies of Ramsay Health Care Limited (ASX: RHC), Sigma also faces the risk of losing one of its major clients in the future.

As we have mentioned before, Sigma and the My Chemist/Chemist Warehouse Group (MC/CW) are currently in a formal negotiation period to seek a commercial resolution to their supply dispute.

MC/CW is intent on acquiring certain products from an alternate wholesaler which would potentially impact Sigma's EBIT by between $5 million and $10 million per year.

The danger here is that if the relationship sours, which I believe it has following Sigma's decision to take legal action, then Sigma could end up losing the entire supply agreement with MC/CW when the contract expires in June 2019.

Overall, considering the tough trading conditions it faces today and the potential loss of the MC/CW contract in the future, I would stay well clear of Sigma for now despite how cheap it may look.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »